Company: HCTI
Filing Date: 2025-10-02
Form Type: PRE 14C
Source: 0001213900-25-095494
Chunk: 7

Company: Healthcare Triangle, Inc.
Filing Date: 2025-10-02
Form: PRE 14C
Chunk 7
---
 you on the SEC’s website at www.sec.gov.
Documents we have filed with the SEC are also available on our website through the investors link at www. https://www.healthcaretriangle.com/.
Information contained on our website does not constitute a part of this prospectus and is not incorporated by reference herein.

You may request a copy of these filings, at no
cost, by writing Healthcare Triangle, Inc. at 7901 Stoneridge Drive, Suite 220, Pleasanton, California 94588 or telephoning the Company
at (925) 270-4812. Any statement contained in a document that is incorporated by reference will be modified or superseded for all purposes
to the extent that a statement contained in this Information Statement (or in any other document that is subsequently filed with the
SEC and incorporated by reference) modifies or is contrary to such previous statement. Any statement so modified or superseded will not
be deemed a part of this Information Statement except as so modified or superseded.

Our common stock is traded on the Nasdaq Capital Market under the
symbol “HCTI.”

Our transfer agent is VStock Transfer, LLC. Their
address is 18 Lafayette Place, Woodmere, New York 11598 and their telephone number is (212) 828-8436.

THIS INFORMATION STATEMENT IS DATED OCTOBER [*], 2025. YOU SHOULD NOT ASSUME THAT THE INFORMATION CONTAINED IN THIS INFORMATION STATEMENT IS ACCURATE AS OF ANY DATE OTHER THAN THAT DATE, AND THE MAILING OF THIS INFORMATION STATEMENT TO STOCKHOLDERS DOES NOT CREATE ANY IMPLICATION TO THE CONTRARY.

This Information Statement is first being mailed
or furnished to stockholders on or about October [*], 2025. The Company will pay all costs associated with the distribution of this Information
Statement, including the costs of printing and mailing. The Company will reimburse brokerage firms and other custodians, nominees and
fiduciaries for reasonable expenses incurred by them in sending this Information Statement to the beneficial owners of the Common Stock.

This Information Statement is provided to the
stockholders only for information purposes in connection with the Certificate of Amendment, pursuant to and in accordance with Rule 14c-2
of the Exchange Act. Please carefully read this Information Statement.

By Order of the Board of Directors:

| Dated: October [*], 2025 | Healthcare Triangle, Inc.      |
|                          | /s/  David Ayanoglou           |
|                          | Name: